Metabomed
company
About
Metabomed designs drugs that treats cancer.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $18M
- Industries
- Biopharma,Biotechnology,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Metabomed designs drugs designed treats cancer. Its drugs target the reprogrammed cancer cell's metabolism to halt their growth, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$18M
Metabomed has raised a total of
$18M
in funding over 2 rounds. Their latest funding was raised on
Apr 4, 2016 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 4, 2016 | Series A | $18M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
